DPP4 and endothelial dysfunction: Therefore, with the treatment of diabetes, which is their primary indication, DPP-4 inhibitors regulate glycemia, covering inflammation, endothelial dysfunction, oxidative stress, and dyslipidemia with favorable pleiotropic effects, and thus suppress the aforementioned risk factors, and prevent disruption of normal cardio-cerebrovascular functioning (Table 1; Figure 1).